Mok CC, Lau CS, Tan SC. Prolactin profile in a cohort of Chinese SLE patients. Br J Rheumatol. 1997;36:986–9.

Article  CAS  PubMed  Google Scholar 

Huang CM, Chou CT. Hyperprolactinemia in SLE. Chin Med J 59: 37–41.

McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. (1991): Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunol. 1997; 147:3780-7.

Walker SE, Jacobson JD. Roles of prolactin and gonadotrophinreleasing hormone in rheumatic Diseases. Rheum Dis Clin North Am. 2000;26:713–36.

Article  CAS  PubMed  Google Scholar 

Hochberg MC, Gravallese EM, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. Elsevier Health Sciences; 2018. 1808 p.

Walker SE. Bromocriptine treatment of systemic lupus erythematosus. Lupus. 2001; 10 (10):762-8. https://doi.org/10.1191/096120301717165010. PMID: 11721704.

Pauzner R, Urowitz MB, Gladman DD, Cough JM. Prolactin in systemic Lupus Erythematosus. J Rheumatol. 1994;21:2064–7.

CAS  PubMed  Google Scholar 

Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic Lupus Erythematosus. J Rheumatol. 1996;23:629–32.

CAS  PubMed  Google Scholar 

Ostendorf B, Fischer R, Santen R, Schmitz-Linneweber B, Specker C, Scheneider M. Hyperprolactinemia in systemic Lupus Erythematosus? Scand J Rheumatol. 1996;25:97–102.

Article  CAS  PubMed  Google Scholar 

Mok CC, Lau CS. Lack of association between prolactin levels and clinical activity in patients with systemic Lupus Erythematosus. J Rheumatol. 1996;23:2185–6.

CAS  PubMed  Google Scholar 

Miranda JM, Prieto RE, Paniagua R, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus. 1998;7:387–91.

Article  CAS  PubMed  Google Scholar 

Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR. Prolactin and interleukin-6 in neuropsychiatric Lupus Erythematosus. Clin Rheumatol. 1998;17:110–14.

Article  CAS  PubMed  Google Scholar 

Aringer M. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum. 2019;49(3S):S14–7. https://doi.org/10.1016/j.semarthrit.2019.09.009. PMID: 31779843.

Article  PubMed  Google Scholar 

Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A Disease activity index for lupus patients. The Committee on Prognosis studies in SLE. Arthritis Rheum. 1992;35(6):630–40. https://doi.org/10.1002/art.1780350606. PMID: 1599520.

Article  CAS  PubMed  Google Scholar 

Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45(239):13–23. https://doi.org/10.1136/adc.45.239.13. PMC 2020414. PMID 5440182.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eren E, Yapıcı Ş, Çakır ED, Ceylan LA, Sağlam H, Tarım Ö. Clinical course of hyperprolactinemia in children and adolescents: a review of 21 cases. J Clin Res Pediatr Endocrinol. 2011;3(2):65–9. https://doi.org/10.4274/jcrpe.v3i2.14. Epub 2011 Jun 8. PMID: 21750634; PMCID: PMC3119443.

Article  PubMed  PubMed Central  Google Scholar 

Falkner B. Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. 2010;25(7):1219–24. https://doi.org/10.1007/s00467-009-1200-3. Epub 2009 May 7. PMID: 19421783; PMCID: PMC2874036.

Article  PubMed  Google Scholar 

Bloem M. The 2006 WHO child growth standards. BMJ. 2007; 334(7596):705-6. https://doi.org/10.1136/bmj.39155.658843.BE. PMID: 17413142; PMCID: PMC1847861.

Thakral A, Klein-Gitelman MS. An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus. Rheumatol Ther. 2016; 3(2):209–219. doi: 10.1007/s40744-016-0044-0. Epub 2016 Sep 30. PMID: 27747587; PMCID: PMC5127968.

Garcia-Prat M, Vila-Pijoan G, Martos Gutierrez S, Gala Yerga G, García Guantes E, Martínez-Gallo M, Martín-Nalda A, Soler-Palacín P, Hernández-González M. Age-specific pediatric reference ranges for immunoglobulins and complement proteins on the Optilite™ automated turbidimetric analyzer. J Clin Lab Anal. 2018;32(6):e22420. Epub 2018 Mar 30. PMID: 29603375; PMCID: PMC6817213.

Article  PubMed  PubMed Central  Google Scholar 

Karimifar M, Tahmasebi A, Bonakdar ZS, Purajam S. Correlation of serum prolactin levels and Disease activity in systematic Lupus Erythematosus. Rheumatol Int. 2011;33(2):511–6.

Article  PubMed  Google Scholar 

Al-Bayyoumy SA, Kadry YA, Mohammad MA, Ismaiel HM. Relation of serum prolactin level to systemic Lupus Erythematosus Disease activity: the effect of immunosuppressive medications. Egypt Rheumatol Rehab. 2007;34:159.

Google Scholar 

Song GG, Lee YH. Circulating prolactin level in systemic Lupus Erythematosus and its correlation with Disease activity: a meta-analysis. Lupus. 2017;26(12):1260–8.

Article  CAS  PubMed  Google Scholar 

Soliman MI, Esawy AM, Khashba SA. Role of prolactin in activity of systemic Lupus Erythematosus. Egypt J Dermatol Venerol. 2018;38:23–8.

Article  Google Scholar 

Jokar M, Maybodi NT, Amini A, Fard MH. Prolactin and macroprolactin in patients with systemic Lupus Erythematosus. Int J Rheum Dis. 2008;11:257–62.

Article  Google Scholar 

Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP, et al. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology. 1997;66:54–62.

Article  CAS  PubMed  Google Scholar 

Jara LJ, Vera-Lastra O, Miranda JM, Alcala M. Alvarez- Nemegyci J. Prolactin in human systemic Lupus Erythematosus. Lupus. 2001;10:748–56.

Article  CAS  PubMed  Google Scholar 

Leanos-Miranda A, Chavez-Rueda KA, Blanco-Favela F. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic Lupus Erythematosus. Arthritis Rheum. 2001;44:866–75.

Article  CAS  PubMed  Google Scholar 

Pando JA, Gourley MF, Wilder RL, Crofford LJ. Hormonal supplementation as treatment for cyclical rashes in patients with systemic Lupus Erythematosus. JRheumatol. 1995;22(1):2159–62.

CAS  Google Scholar 

Castillo JM, Sánchez MA, Márquez AM. Prolactin as a marker of active Disease in systemic Lupus Erythematosus. Int J Biomedical Eng Clin Sci. 2021;7(4):73–6. https://doi.org/10.11648/j.ijbecs.20210704.11.

Article  Google Scholar 

Peeva E, Michael D, Cleary J, Rice J, Chen X, Diamond B. Prolactin modulates the naive B cell repertoire. J Clin Invest. 2003;111(2):275–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carreño PC, Sacedón R, Jiménez E, Vicente A, Zapata AG. Prolactin affects both survival and differentiation of T-cell progenitors. J Neuroimmunol. 2005;160(1):135–45.

Article  PubMed  Google Scholar 

Saha S, Gonzalez J, Rosenfeld G, Keiser H, Peeva E. (2009): Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum. 2009; 60(6):1743-52.

Fojtikova MT, Tomasová Studýnková J, Filkova M, Lacinova Z, Gatterova J, Pavelka K, et al. Elevated prolactin levels in patients with rheumatoid arthritis: association with Disease activity and structural damage. Clin Exp RheumatolIncl Supp. 2010;28(6):849.

CAS  Google Scholar 

Rovensky J, Kvetnansky R, Radikova Z, Imrich R, Greguska O, Vigas M, et al. Hormone concentrations in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(3):292–6.

CAS  PubMed  Google Scholar 

Tolis G, Goldstein M, Friesen HG. Functional evaluation on prolactin secretion in patients with hypothalamic-pituitary disorders. J Clin Invest. 1993;52:783–8.

Article  Google Scholar 

Stuart MC, Underwood PA, Boscato L. A monoclonal antibody suitable for the radioimmunoassay for human prolactin. J Clin Endocrinol Metab. 1984;54:881–4.

Article  Google Scholar 

Jara LJ, Vera-Lastra O, Miranda JM, Alcala. M and Alvarez-Nemegyei, J. Prolactin in human systemic Lupus Erythematosus. Lupus. 2001;10:748–56.

Article  CAS  PubMed  Google Scholar 

Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune Diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune Diseases. Ann NY Acad Sci. 2007;1109:385–400.

Article  CAS  PubMed  Google Scholar 

Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic Lupus Erythematosus: PRL levels are related to the Disease activity. Lupus. 2001;10:554–61.

Article  CAS  PubMed  Google Scholar 

Zhu X, Xu J, Li S, Huang W, Li F. Role of abnormal anterior pituitary hormones-growth hormone and prolactin in active systemic Lupus Erythematosus. Int J Clin Exp Med. 2015;8:19223–31.

CAS  PubMed  PubMed Central  Google Scholar 

El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S. Prolactin hormone in juvenile systemic Lupus Erythematosus: a possible relationship to Disease activity and CNS manifestations. J Rheumatol. 1996;23(2):374–7. PMID: 8882050.

CAS  PubMed  Google Scholar 

Vera-Lastra O, Jara LJ, Espinoza LR. Prolactin and autoimmunity. Autoimmun Rev. 2002;1(6):360–4. https://doi.org/10.1016/s1568-9972(02)00081-2.

Article  CAS  PubMed  Google Scholar 

Pacilio M, Migliaresi S, Meli R, Ambrosono L, Bigliardo B, Di Carlo R. Elevated bioactive levels in systemic Lupus Erythematosus — association with Disease activity. J Rheumatol. 2001;28:2216–21.

CAS  PubMed  Google Scholar 

Jara LJ, Vera-Lastra O, Miranda JM, Alcala M. Alvarez- Nemegyei J. Prolactin in human systemic Lupus Erythematosus. Lupus. 2001;10:748–56.

Article